{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:25:00Z","timestamp":1794702300757,"version":"4.9.1"},"reference-count":18,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,2,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mutations in isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) occur in most grade 2 and 3 gliomas, secondary glioblastomas, and a subset of acute myelogenous leukemias but have not been detected in other tumor types. The mutations occur at specific arginine residues and result in the acquisition of a novel enzymatic activity that converts 2-oxoglutarate to D-2-hydroxyglutarate. This study reports IDH1 and IDH2 genotyping results from a set of lymphomas, which included a large set of peripheral T-cell lymphomas. IDH2 mutations were identified in approximately 20% of angioimmunoblastic T-cell lymphomas (AITLs), but not in other peripheral T-cell lymphoma entities. These results were confirmed in an independent set of AITL patients, where the IDH2 mutation rate was approximately 45%. This is the second common genetic lesion identified in AITL after TET2 and extends the number of neoplastic diseases where IDH1 and IDH2 mutations may play a role.<\/jats:p>","DOI":"10.1182\/blood-2011-11-391748","type":"journal-article","created":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T03:18:54Z","timestamp":1325647134000},"page":"1901-1903","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":469,"title":["IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma"],"prefix":"10.1182","volume":"119","author":[{"given":"Rob A.","family":"Cairns","sequence":"first","affiliation":[{"name":"Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital, University Health Network, Toronto, ON;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javeed","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lemonnier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Est, Inserm U955, Department of Pathology, H\u00f4pital Henri Mondor, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Kucuk","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Centre Hospitalier Universitaire (CHU) Vandois University Hospital of Lausanne, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Jais","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Descartes, Assistance Publique\u2013Hopitaux de Paris (AP-HP), H\u00f4pital Necker, Service de Biostatistique, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Parrens","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pathologie, H\u00f4pital du Haut l'\u00c9v\u00eaque, Pessac, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Pathology, AP-HP, CHU de Bobigny, Bobigny, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Xerri","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Institut Paoli-Calmettes, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brousset","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Paul Sabatier Toulouse III and Cancer Research Center of Toulouse, Unit\u00e9 Mixte de Recherche 1037, CHU Purpan, Toulouse, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Chong","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Chung","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Est, Inserm U955, Department of Pathology, H\u00f4pital Henri Mondor, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tak W.","family":"Mak","sequence":"additional","affiliation":[{"name":"Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital, University Health Network, Toronto, ON;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5897","key":"2019111808213913100_B1","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme.","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"issue":"11","key":"2019111808213913100_B2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome.","volume":"361","author":"Mardis","year":"2009","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111808213913100_B3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas.","volume":"360","author":"Yan","year":"2009","journal-title":"N Engl J Med"},{"issue":"7274","key":"2019111808213913100_B4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"issue":"2","key":"2019111808213913100_B5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20092506","article-title":"Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.","volume":"207","author":"Gross","year":"2010","journal-title":"J Exp Med"},{"issue":"6","key":"2019111808213913100_B6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"issue":"49","key":"2019111808213913100_B7","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1038\/onc.2010.444","article-title":"Cancer-associated IDH mutations: biomarker and therapeutic opportunities.","volume":"29","author":"Yen","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"2019111808213913100_B8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/humu.20937","article-title":"IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.","volume":"30","author":"Bleeker","year":"2009","journal-title":"Hum Mutat"},{"issue":"2","key":"2019111808213913100_B9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ijc.24379","article-title":"Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers.","volume":"125","author":"Kang","year":"2009","journal-title":"Int J Cancer"},{"key":"2019111808213913100_B10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/asheducation.V2008.1.272.0010272","article-title":"Pathobiology and molecular profiling of peripheral T-cell lymphomas.","volume":"2008","author":"de Leval","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"5","key":"2019111808213913100_B11","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111808213913100_B12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ng1975","article-title":"High-throughput oncogene mutation profiling in human cancer.","volume":"39","author":"Thomas","year":"2007","journal-title":"Nat Genet"},{"issue":"1","key":"2019111808213913100_B13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"issue":"5","key":"2019111808213913100_B14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma.","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111808213913100_B15","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019111808213913100_B16","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood-2006-01-0394","article-title":"Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells.","volume":"108","author":"Krenacs","year":"2006","journal-title":"Blood"},{"issue":"11","key":"2019111808213913100_B17","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2019111808213913100_B18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood-2010-12-322479","article-title":"The prognostic significance of IDH2 mutations in AML depends on the location of the mutation.","volume":"118","author":"Green","year":"2011","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/8\/1901\/1355145\/zh800812001901.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/8\/1901\/1355145\/zh800812001901.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T08:42:16Z","timestamp":1574066536000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/8\/1901\/30392\/IDH2-mutations-are-frequent-in-angioimmunoblastic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,23]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,2,23]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-11-391748","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,23]]}}}